PRN Meeting: April 12, 2023 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Course Moderator: Keith A. LaScalea, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College

Guest Speakers and Presentations:

Update on Inflammation, Aging, and CMV Co-Infection in Treated HIV

Peter W. Hunt, MD

Professor of Medicine, Division of Experimental Medicine, UCSF
Co-Director of Basic/Translational Sciences, Center for AIDS Research
San Francisco, CA

At the completion of this educational session, learners will:
1.  Be aware of the causes and putative consequences of persistent inflammation in treated HIV
2.  Know the current strategies being pursued to decrease immune activation and multimorbidity in treated HIV.
3.  Understand the evidence suggesting that CMV may play an important role in multimorbidity in treated HIV as well as COVID-19 complications.

Body Fat Changes with Aging in People with HIV: Implications for Healthspan and Lifespan

Todd T. Brown, MD, PhD

Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes,  and Metabolism
Johns Hopkins University, Baltimore, MD

At the completion of this educational session, learners will:
1. Understand how body fat changes with aging.
2. Know about the various fat depots and their associations with health outcomes.
3. Be aware of how body fat changes may differ in people with HIV, what factors may influence these differences, and what this means for aging in people with HIV.

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York designates this live activity for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

As an ACCME-accredited provider, MSSNY is required to identify and mitigate relevant financial relationships of all individuals in control of CME content. Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education: A financial relationship, in any amount, exists between the person in control of content and an ineligible company; The financial relationship existed during the past 24 months; The content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Dr. James F. Braun (Planner/Course Director/ Moderator) has no relevant financial relationships to disclose. Dr. Keith A. LaScalea (Course Moderator) has no relevant financial relationships to disclose. Dr. Peter W. Hunt (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to: Merck, ViiV and Biotron; Drug donation for trial from: Merck; Research grant from: Gilead; Honoraria from: ViiV and Gilead. Dr. Hunt will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated. Dr. Todd T. Brown (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to: ViiV, Gilead, Janssen and Merck. Dr. Brown will submit his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare